The number of Israelis receiving medical cannabis has fallen for the first time since 2011. Researcher argues decline not a reflection of improvement in health but of stricter HMO gatekeeping.

Employee tends to medical cannabis plants at Pharmocann, an Israeli medical cannabis company in northern Israel

(photo credit: AMIR COHEN/REUTERS)